These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17092863)

  • 1. Trends in on and off-label calcipotriene use.
    Pearce DJ; Camacho F; Balkrishnan R; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2006; 17(5):308-13. PubMed ID: 17092863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoriasis treatment in the United States at the end of the 20th century.
    Pearce DJ; Stealey KH; Balkrishnan R; Fleischer AB; Feldman SR
    Int J Dermatol; 2006 Apr; 45(4):370-4. PubMed ID: 16650160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of vitamin D analog use for the treatment of psoriasis.
    Ahn CS; Awadalla F; Huang KE; Yentzer B; Dabade TS; Feldman SR
    J Drugs Dermatol; 2013 Aug; 12(8):906-10. PubMed ID: 23986164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in older adult psoriasis outpatient health care practices in the United States.
    Wong JW; Davis SA; Feldman SR; Koo JY
    J Drugs Dermatol; 2012 Aug; 11(8):957-62. PubMed ID: 22859241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing use of more potent treatments for psoriasis.
    Strowd LC; Yentzer BA; Fleischer AB; Feldman SR
    J Am Acad Dermatol; 2009 Mar; 60(3):478-81. PubMed ID: 19058875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in pediatric psoriasis outpatient health care delivery in the United States.
    Vogel SA; Yentzer B; Davis SA; Feldman SR; Cordoro KM
    Arch Dermatol; 2012 Jan; 148(1):66-71. PubMed ID: 21931013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in off-label beta-blocker use: a secondary data analysis.
    Lin HW; Phan K; Lin SJ
    Clin Ther; 2006 Oct; 28(10):1736-46; discussion 1710-1. PubMed ID: 17157130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy for psoriasis in the United States.
    Davis SA; Feldman SR
    J Drugs Dermatol; 2013 May; 12(5):546-50. PubMed ID: 23652949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of psoriasis: role of calcipotriene.
    Kirsner RS; Federman D
    Am Fam Physician; 1995 Jul; 52(1):237-40, 243-4. PubMed ID: 7604767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using a single product (calcipotriene/betamethasone topical suspension) vs multiple products to manage body and scalp psoriasis: comparisons in resource utilization and costs.
    Feldman SR; Levi E; Pathak P; Kakatkar S; Balkrishnan R
    J Med Econ; 2013 Dec; 16(12):1405-13. PubMed ID: 24063352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting prescription of ultra-high potency topical corticosteroids in skin disease: an analysis of US national practice data.
    Balkrishnan R; Camacho FT; Pearce DJ; Kulkarni AS; Spencer L; Fleischer AB; Feldman SR
    J Drugs Dermatol; 2005; 4(6):699-706. PubMed ID: 16302555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of topical calcipotriene/calcipotriol in conditions other than plaque-type psoriasis.
    Thiers BH
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S69-71. PubMed ID: 9344189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcipotriene for psoriasis.
    Med Lett Drugs Ther; 1994 Aug; 36(928):70-1. PubMed ID: 8035754
    [No Abstract]   [Full Text] [Related]  

  • 14. An unusual bullous eruption in a patient with psoriasis: Calcipotriene phototoxicity.
    Anolik R; Brauer JA; Soter NA
    J Am Acad Dermatol; 2010 Jun; 62(6):1081-2. PubMed ID: 20466193
    [No Abstract]   [Full Text] [Related]  

  • 15. Calcipotriene/betamethasone in the treatment of psoriasis: a review article.
    Saraceno R; Gramiccia T; Frascione P; Chimenti S
    Expert Opin Pharmacother; 2009 Oct; 10(14):2357-65. PubMed ID: 19663634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A betamethasone-calcipotriene combination for psoriasis.
    Med Lett Drugs Ther; 2006 Jul; 48(1238):55-6. PubMed ID: 16841023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    Jemec GB; Ganslandt C; Ortonne JP; Poulin Y; Burden AD; de Unamuno P; Berne B; Figueiredo A; Austad J
    J Am Acad Dermatol; 2008 Sep; 59(3):455-63. PubMed ID: 18694678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcipotriene ointment 0.005% for psoriasis: a safety and efficacy study. Calcipotriene Study Group.
    Highton A; Quell J
    J Am Acad Dermatol; 1995 Jan; 32(1):67-72. PubMed ID: 7822519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasis in infancy: therapy with calcipotriene ointment.
    Travis LB; Silverberg NB
    Cutis; 2001 Nov; 68(5):341-4. PubMed ID: 11766119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypharmacy trends in office visits by the elderly in the United States, 1990 and 2000.
    Aparasu RR; Mort JR; Brandt H
    Res Social Adm Pharm; 2005 Sep; 1(3):446-59. PubMed ID: 17138489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.